Latest Breaking News On - Genitourinary cancers - Page 4 : comparemela.com

Dr Garmezy on the Impact of Combination Regimens on Outcomes and Quality of Life in Patients With RCC

Benjamin Garmezy, MD, discusses the impact of frontline combination regimens on patient outcomes in patients with renal cell carcinoma.

Garmezy Highlights Ongoing and Future Research Directions Across RCC Subtypes

Benjamin Garmezy, MD, provides an overview of recent data on immuno-oncology/TKI combination data in variant renal cell carcinoma.

What's Going On With Cancer-Focused Corbus Pharmaceuticals Stock Today? - Corbus Pharmaceuticals (NASDAQ:CRBP)

Corbus Pharmaceuticals announces a $82.2M public offering at $19.00 per share. Explore latest updates on CRB-701 clinical study.

Cancer Run, presented by Cleveland Clinic Abu Dhabi, set to kick off on February 4 to mark World Cancer Day

Highlights from the Gastrointestinal and Genitourinary Cancer Conferences

Here are some of the top stories from the recent Gastrointestinal Cancers Symposium as well as the Genitourinary Cancers Symposium.